Current and Future Landscape of RNA-Based Drugs and Impact of COVID-19 Vaccines Success
Summary
This report investigates the past, current and future landscape of RNA-Based drugs, and how the success of the COVID-19 vaccines may have impacted this. High level analysis of the key trends and movements within the pharmaceutical industry in reference to RNA technology is provided, allowing you to identify and discern the key points within this area.
Scope
This 42-page report gives important, expert insight that you won’t find in any other source. 13 curated figures throughout the report illustrate major points and trends relating to RNA-Based drugs and the impact of COVID-19. This report is required reading for:
- Investors that want to understand the current and future RNA-Based drug trends, as well as identifying companies to invest in.
- Companies that are interesting in identifying the current landscape for RNA-Based drugs, as well as the forecast future landscape.
- Large companies with investment groups or BD teams looking to see which companies are predicted to lead the RNA-Based drug landscape in the near and far future.
- Small and medium pharma who want to focus their drug portfolio on future trends regarding RNA technology, and are looking for partnership opportunities.
Insights on RNA-Based Drug Approval trends
Insights on active companies with RNA-Based drugs
Insights on RNA-Based drugs by development stage
Insights on deals involving RNA-Based drugs
Insights on RNA-Based drug clinical trial trends
Insights on RNA-Based forecast sale values
Insights on major upcoming RNA-Based Drug launches
- 1 Executive Summary
- 2 RNA-Based Drugs and the Impact of COVID-19
- 2.1 An introduction to RNA-based drugs
- 2. 2 The impact of COVID-19
- 3 An Overview of the Current RNA-Based Drug Landscape
- 3.1 Approval timeline of RNA-based drugs
- 3.2 Top companies in RNA technology
- 3.3 RNA drugs by development stage
- 3.4 Yearly change in active RNA-based drug count
- 4 Major Post-Pandemic Changes to the RNA-Based Landscape
- 4.1 Changes in deal volume and deal values
- 4.2 Awarding of review designation by molecule type
- 4.3 Changes of clinical trial trends
- 5 RNA-Based Drugs; The Future Perspective
- 5.1 RNA drug sales by therapy area, company and molecule type
- 5.2 Top upcoming RNA-based drug launches
- 6 Key Findings
- 7 Appendix
- 7.1 Abbreviations
- 7.2 Methodology
- 7.3 Related Reports
- 7.4 About the Authors
- 7.5 About GlobalData
- 7.6 Contact Us
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook